For the Inventor, By the Inventor

Enter assignee name

Boston, MA, United States of America

The Beth Israel Hospital Association

USPTO Granted Patents = 80

CIPO Patents = 1

Forward Citations = 4,755

Loading Chart...

Loading Chart...

99 inventors (with patents filed for the assignee):

Terry Barton Strom (13 out of 35 patents)

Eric Thor Fossel (8 out of 33 patents)

Richard J Sharpe (4 out of 10 patents)

4. Xin Xiao Zheng (3 out of 10 patents)

5. Alan Steele (3 out of 4 patents)

6. John R Ives (3 out of 7 patents)

7. Jeffrey S Flier (3 out of 11 patents)

8. Stephen J Galli (3 out of 10 patents)

9. Kenneth A Arndt (3 out of 9 patents)

10. J Richard Spears (3 out of 3 patents)

11. Stephen J Kleshinski (2 out of 45 patents)

12. Peter C Meltzer (2 out of 30 patents)

13. Chaker N Adra (2 out of 8 patents)

14. Donald R Senger (2 out of 6 patents)

15. Howard Paul Sard (2 out of 27 patents)

Core Competencies:

Diabetes Treatment

Chimeric IL-10 Proteins

Gene Therapy

Allograft Rejection

Transgenic Animal Models

Electroencephalography

Immunosuppressant Agents

Nuclear Magnetic Resonance

Oxidized Lipoproteins

Cancer Detection

Fistula Generation

Autoimmune Disease Treatment

80 patents: Sort by Forward Citations

1. 6770272 - Treatment of diabetes (2004-08-03),

2. 6410008 - Chimeric IL-10 proteins and uses thereof (2002-06-25),

3. 6403077 - Treatment regimes featuring an IL-10-containing chimeric polypeptide (2002-06-11),

4. 6113900 - Use of IL-2 receptor-targeted therapeutics to inhibit allograft (2000-09-05),

5. 6099542 - Catheter apparatus and methodology for generating a fistula on-demand (2000-08-08),

6. 6068837 - Mesothelial cell gene therapy (2000-05-30),

7. 5958403 - Methods and compounds for prevention of graft rejection (1999-09-28),

8. 5916559 - Use of interleukin-2 (IL-2) receptor-specific agents to treat allograft (1999-06-29),

9. 5869230 - Gene transfer into the kidney (1999-02-09),

10. 5789654 - Transgenic animals deficient in endogenous .beta..sub.3 -adrenergic (1998-08-04),

11. 5776465 - Recombinant mycobacterial vaccines (1998-07-07),

12. 5767073 - D4 gene and methods of use thereof (1998-06-16),

13. 5717062 - Cyclic analogs of PTH and PTHrP (1998-02-10),

14. 5704369 - Non-invasive method for diagnosing Alzeheimer's disease in a patient (1998-01-06),

15. 5686408 - Method for modifying, diagnosing, and screening for IGF-I sensitive cell (1997-11-11),

Beth Israel Deaconess Medical Center (BIDMC) is a world-class teaching hospital affiliated with Harvard Medical School. BIDMC is recognized for excellence in patient care, biomedical research, education, and community service. As one of Boston's leading hospitals, BIDMC provides a full range of medical services, including primary care, specialty care, and advanced treatments. With a commitment to innovation and compassionate care, BIDMC continues to be at the forefront of medical advancements.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

80 Patents

#28 in Boston, MA

#245 in Massachusetts

#4,472 in US

#9,189 in the World

Boston, MA, United States of America

The Beth Israel Hospital Association

Forward Citations = 4,755

99 inventors:

Terry Barton Strom (13 out of 35 patents)

Eric Thor Fossel (8 out of 33 patents)

Richard J Sharpe (4 out of 10 patents)

4. Xin Xiao Zheng (3 out of 10 patents)

5. Alan Steele (3 out of 4 patents)

Please report any incorrect information to support@idiyas.com

Loading…